EBSAM
AMED

Eubel Brady & Suttman Asset Management’s Amedisys AMED Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,239
Closed -$811K – 111
2025
Q2 		$811K Buy
8,239
+1,358
+20% +$128K 0.1% 57
2025
Q1 		$637K Sell
6,881
-1,620
-19% -$149K 0.08% 61
2024
Q4 		$772K Buy
8,501
+62
+0.7% +$5.69K 0.1% 59
2024
Q3 		$814K Hold
8,439
– – 0.11% 58
2024
Q2 		$775K Buy
8,439
+3,368
+66% +$313K 0.11% 60
2024
Q1 		$467K Buy
5,071
+2,483
+96% +$233K 0.06% 68
2023
Q4 		$246K Hold
2,588
– – 0.03% 84
2023
Q3 		$242K Hold
2,588
– – 0.04% 86
2023
Q2 		$237K Buy
+2,588
New +$212K 0.03% 84
2021
Q3 		– Sell
-100
Closed -$26K – 82
2021
Q2 		$26K Buy
+100
New +$26.2K ﹤0.01% 423

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's AMED Position: Q3 2025 in Review

Eubel Brady & Suttman Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 8,239 shares — an estimated $811K sold.

Eubel Brady & Suttman Asset Management first reported a position in AMED in Q2 2021 and held it in 10 quarters. The position peaked at $814K in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Eubel Brady & Suttman Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Eubel Brady & Suttman Asset Management sold 8,239 Amedisys shares in Q3 2025, an estimated $811K.
  • Eubel Brady & Suttman Asset Management first reported a position in Amedisys in Q2 2021 and held it in 10 quarters.
  • Eubel Brady & Suttman Asset Management's Amedisys position peaked at $814K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.